Paul H.A. Quax

16.0k citations

295 papers · 11.7k indexed · h-index 59

Cancer Research top 0.2%
- Protease and Inhibitor Mechanisms 60
- MicroRNA in disease regulation 24
- Cancer-related molecular mechanisms research 19
Immunology and Allergy top 0.5%
- Cell Adhesion Molecules Research 43
Immunology top 0.5%
- Atherosclerosis and Cardiovascular Diseases 54
Hematology top 1%
- Blood Coagulation and Thrombosis Mechanisms 36
Molecular Biology top 1%
- Angiogenesis and VEGF in Cancer 60
Surgery
- Coronary Interventions and Diagnostics 36

Co-authors: Margreet R. de Vries J. Wouter Jukema Victor W.M. van Hinsbergh Jan H. Verheijen Jos Grimbergen A. Yaël Nossent Gerard Pasterkamp Marten A. Engelse
Cited by: Cancer Research Immunology and Allergy Immunology
Journals: Proceedings of the National Academy of Sciences (2 papers)Journal of Biological Chemistry (2 papers)Circulation (8 papers)
Partner nations: Netherlands United States Germany

In The Last Decade

Paul H.A. Quax

292 papers receiving 11.5k citations

Peers

Countries citing papers authored by Paul H.A. Quax

Since Specialization

Citations

This map shows the geographic impact of Paul H.A. Quax's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul H.A. Quax with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul H.A. Quax more than expected).

Fields of papers citing papers by Paul H.A. Quax

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paul H.A. Quax. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul H.A. Quax. The network helps show where Paul H.A. Quax may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Paul H.A. Quax, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Paul H.A. Quax Line = papers co-authored together Paul H.A. Quax links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	N-6-Methyladenosine in Vasoactive microRNAs during Hypoxia; A Novel Role for METTL4 International Journal of Molecular Sciences ·Daphne A. L. van den Homberg,Reginald V. C. T. van der Kwast,Paul H.A. Quax,A. Yaël Nossent	2022	28
2	Short Hairpin RNA Gene Silencing of Prolyl Hydroxylase-2 with a Minicircle Vector Improves Neovascularization of Hindlimb Ischemia Human Gene Therapy ·M.A. Lijkwan,A.A. Hellingman,Ernst Jan Bos,Koen E.A. van der Bogt,Mei Huang,Nigel G. Kooreman,Margreet R. de Vries,Hendrika A. B. Peters,Robert C. Robbins,Jaap F. Hamming,Paul H.A. Quax,Joseph C. Wu	2013	28
3	Annexin A5 prevents post-interventional accelerated atherosclerosis development in a dose-dependent fashion in mice Atherosclerosis ·M.M. Ewing,Jacco C. Karper,M. Lourdes Sampietro,Margreet R. de Vries,K. Pettersson,J. Wouter Jukema,Paul H.A. Quax	2012	24
4	Abstract 15644: A Fully Human Monoclonal IgG Phosphorylcholine Antibody Prevents Accelerated Atherosclerosis in Mice Circulation ·Knut Pettersson,M.M. Ewing,Margreet R. de Vries,Rajai Atout,Mariette Nordzell,Daniel J. Sexton,Frédéric Charlotte,J. Wouter Jukema,Ewa Ninio,Sonia Karabina,Paul H.A. Quax	2011	2
5	SNPs in MicroRNA Binding Sites in 3′-UTRs of RAAS Genes Influence Arterial Blood Pressure and Risk of Myocardial Infarction American Journal of Hypertension ·A. Yaël Nossent,Jakob L. Hansen,Carine J.M. Doggen,Paul H.A. Quax,Søren P. Sheikh,Frits R. Rosendaal	2011	75
6	A limited role for regulatory T cells in post‐ischemic neovascularization Journal of Cellular and Molecular Medicine ·A.A. Hellingman,Luciën E. P. M. van der Vlugt,M.A. Lijkwan,A.J.N.M. Bastiaansen,Tim Sparwasser,Hermelijn H. Smits,Jaap F. Hamming,Paul H.A. Quax	2011	19
7	Epigenetic control of CCR5 transcript levels in immune cells and modulation by small molecules inhibitors Journal of Cellular and Molecular Medicine ·Rutger J. Wierda,Hedwich F. Kuipers,Marja C.J.A. van Eggermond,Anne Benard,Jan C. van Leeuwen,Silvia Carluccio,Sacha B. Geutskens,J. Wouter Jukema,Víctor E. Márquez,Paul H.A. Quax,Peter J. van den Elsen	2011	22
8	Abstract 14685: RP105, A Cell Surface TLR4 Signaling Regulator, Enhances Atherosclerotic Plaque Formation Circulation ·Jacco C. Karper,Saskia C.A. de Jager,M.M. Ewing,J. Wouter Jukema,Johan Kuiper,Paul H.A. Quax	2011	1
9	Annexin A5: genotypic risk marker for clinical restenosis after percutaneous coronary intervention European Heart Journal ·M.M. Ewing,Jeffrey J. W. Verschuren,M. Lourdes Sampietro,Margreet R. de Vries,Peter de Knijff,Paul H.A. Quax,J. Wouter Jukema	2010	1
10	In vivo suppression of vein graft disease by nonviral, electroporation-mediated, gene transfer of tissue inhibitor of metalloproteinase-1 linked to the amino terminal fragment of urokinase (TIMP-1.ATF), a cell-surface directed matrix metalloproteinase inhibitor Journal of Vascular Surgery ·D. Eefting,Margreet R. de Vries,Jos Grimbergen,Jacco C. Karper,J. Hajo van Bockel,Paul H.A. Quax	2009	15
11	Local lentiviral short hairpin RNA silencing of CCR2 inhibits vein graft thickening in hypercholesterolemic apolipoprotein E3-Leiden mice Journal of Vascular Surgery ·D. Eefting,Ilze Bot,Margreet R. de Vries,Abbey Schepers,J. Hajo van Bockel,Theo J.C. van Berkel,Erik A.L. Biessen,Paul H.A. Quax	2009	34
12	Critical Role of Tissue Kallikrein in Vessel Formation and Maturation Arteriosclerosis Thrombosis and Vascular Biology ·Oliver A. Stone,Christine Richer,Costanza Emanueli,Vincent van Weel,Paul H.A. Quax,Rajesh Katare,N Kraenkel,Paola Campagnolo,Lucíola S. Barcelos,Mauro Siragusa,Graciela B. Sala‐Newby,Danila Baldessari,Marina Mione,Marie Vincent,Andrew V. Benest,Ayman Al Haj Zen,Julien Gonzalez,David O. Bates,François Alhenc‐Gelas,Paolo Madeddu	2009	48
13	Epigenetic histone acetylation modifiers in vascular remodelling: new targets for therapy in cardiovascular disease European Heart Journal ·Douwe Pons,F. R. de Vries,Peter J. van den Elsen,Bastiaan T. Heijmans,Paul H.A. Quax,J. Wouter Jukema	2008	138
14	Inhibition of neointima formation by local delivery of estrogen receptor alpha and beta specific agonists Cardiovascular Research ·Yvonne D. Krom,Nuno Pires,J. Wouter Jukema,Margreet R. de Vries,Rune R. Frants,L.M. Havekes,K VANDIJK,Paul H.A. Quax	2006	18
15	Short-term dexamethasone treatment inhibits vein graft thickening in hypercholesterolemic ApoE3Leiden transgenic mice Journal of Vascular Surgery ·Abbey Schepers,Nuno Pires,D. Eefting,Margreet R. de Vries,J. Hajo van Bockel,Paul H.A. Quax	2006	24
16	Drug-eluting stents studies in mice: Do we need atherosclerosis to study restenosis? Vascular Pharmacology ·Nuno Pires,J. Wouter Jukema,Mat J.A.P. Daemen,Paul H.A. Quax	2006	8
17	The effect of interleukin-10 knock-out and overexpression on neointima formation in hypercholesterolemic APOE3-Leiden mice Atherosclerosis* ·D. Eefting,Abbey Schepers,Margreet R. de Vries,Nuno Pires,Jos Grimbergen,Tonny Lagerweij,Lex Nagelkerken,Pascalle S. Monraats,J. Wouter Jukema,J. Hajo van Bockel,Paul H.A. Quax	2006	34
18	Urokinase-Receptor/Integrin Complexes Are Functionally Involved in Adhesion and Progression of Human Breast Cancer in Vivo American Journal Of Pathology ·Gabri van der Pluijm,Bianca Sijmons,H J Vloedgraven,Chris van der Bent,Jan W. Drijfhout,J.a.n. Verheijen,Paul H.A. Quax,Marcel Karperien,Socrates E. Papapoulos,Clemens W.G.M. Löwik	2001	79
19	The Plasminogen Activator System in Extracellular Matrix Degradation Research at the University of Copenhagen (University of Copenhagen) ·Paul H.A. Quax,(unknown),(unknown),(unknown),Y. Schrauwen,Georgia Barlovatz‐Meimon,(unknown),(unknown)	1992	10
20	Complementation between urokinase-producing and receptor-producing cells in extracellular matrix degradation. PubMed ·Paul H.A. Quax,Nina Marie Pedersen,Maria Teresa Masucci,E J Weening-Verhoeff,Keld Danø,Jan H. Verheijen,Francesco Blasi	1991	80

About Paul H.A. Quax

Paul H.A. Quax is a scholar working on Immunology and Allergy, Cancer Research and Immunology, having authored 295 papers that have together received 11.7k indexed citations. Recurring topics across this work include Protease and Inhibitor Mechanisms (60 papers), Angiogenesis and VEGF in Cancer (60 papers), Atherosclerosis and Cardiovascular Diseases (54 papers), Cell Adhesion Molecules Research (43 papers), Blood Coagulation and Thrombosis Mechanisms (36 papers), Coronary Interventions and Diagnostics (36 papers), MicroRNA in disease regulation (24 papers) and Cancer-related molecular mechanisms research (19 papers). The work is most often cited by research in Cancer Research (3.0k citations), Immunology and Allergy (1.0k citations) and Immunology (2.6k citations). Paul H.A. Quax has collaborated with scholars based in Netherlands, United States and Germany. Frequent co-authors include Margreet R. de Vries, J. Wouter Jukema, Victor W.M. van Hinsbergh, Jan H. Verheijen, Jos Grimbergen, A. Yaël Nossent, Gerard Pasterkamp, Marten A. Engelse, J. Hajo van Bockel and Imo E. Hoefer. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Circulation.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact